Squarepoint Ops LLC Invests $132,000 in Pediatrix Medical Group, Inc. (NYSE:MD)

Squarepoint Ops LLC acquired a new position in shares of Pediatrix Medical Group, Inc. (NYSE:MD) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund acquired 10,049 shares of the company’s stock, valued at approximately $132,000.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. XTX Topco Ltd acquired a new position in Pediatrix Medical Group in the 4th quarter valued at $169,000. SG Americas Securities LLC acquired a new position in Pediatrix Medical Group in the 4th quarter valued at $171,000. Principal Financial Group Inc. increased its stake in Pediatrix Medical Group by 7.5% in the 4th quarter. Principal Financial Group Inc. now owns 551,924 shares of the company’s stock valued at $7,241,000 after buying an additional 38,306 shares during the period. Deutsche Bank AG increased its stake in Pediatrix Medical Group by 53.1% in the 4th quarter. Deutsche Bank AG now owns 74,023 shares of the company’s stock valued at $971,000 after buying an additional 25,663 shares during the period. Finally, Smartleaf Asset Management LLC increased its stake in Pediatrix Medical Group by 750.9% in the 4th quarter. Smartleaf Asset Management LLC now owns 6,901 shares of the company’s stock valued at $91,000 after buying an additional 6,090 shares during the period. Hedge funds and other institutional investors own 97.71% of the company’s stock.

Pediatrix Medical Group Stock Performance

MD stock opened at $14.13 on Tuesday. The company has a debt-to-equity ratio of 0.81, a quick ratio of 1.42 and a current ratio of 1.60. The stock has a market capitalization of $1.21 billion, a price-to-earnings ratio of -11.78, a PEG ratio of 1.74 and a beta of 1.27. Pediatrix Medical Group, Inc. has a 1 year low of $6.62 and a 1 year high of $17.67. The stock’s fifty day moving average is $13.64 and its two-hundred day moving average is $14.00.

Pediatrix Medical Group (NYSE:MD) last issued its quarterly earnings data on Tuesday, May 6th. The company reported $0.33 earnings per share for the quarter, beating analysts’ consensus estimates of $0.25 by $0.08. The business had revenue of $458.36 million for the quarter, compared to analysts’ expectations of $451.44 million. Pediatrix Medical Group had a negative net margin of 4.92% and a positive return on equity of 15.47%. The company’s revenue was down 7.4% on a year-over-year basis. During the same period in the previous year, the business earned $0.20 earnings per share. On average, research analysts predict that Pediatrix Medical Group, Inc. will post 1.38 EPS for the current year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on MD shares. Macquarie upped their price target on shares of Pediatrix Medical Group from $19.00 to $20.00 and gave the stock an “outperform” rating in a research note on Thursday, May 8th. Truist Financial lowered their price objective on shares of Pediatrix Medical Group from $18.00 to $16.00 and set a “hold” rating on the stock in a research note on Friday, April 11th. Finally, UBS Group lowered their price objective on shares of Pediatrix Medical Group from $18.50 to $16.00 and set a “neutral” rating on the stock in a research note on Monday, May 12th. Four analysts have rated the stock with a hold rating and three have given a buy rating to the company’s stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $16.67.

About Pediatrix Medical Group

Pediatrix Medical Group, Inc, together with its subsidiaries, provides newborn, maternal-fetal, pediatric cardiology, and other pediatric subspecialty care services in the United States. It offers neonatal care services, such as clinical care to babies born prematurely or with complications within specific units at hospitals through neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians.